⌘K
Loading ticker…
As of 2026-08-24, Kura Oncology, Inc. (KURA) has a 3-month relative strength percentile of 67 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 1.47×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
KURA is held by 21 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $4M notional. Top 3 carry $11M.
Held by 52 ETFs · $107M across latest filings · largest weight 1.38% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.02% | $4M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $4M | — |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| SBIO | 0.57% | $929K | +0.08 pp |
| GSSC | 0.08% | $769K | −0.02 pp |
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $678K |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $485K | — |
| OMFS | 0.09% | $252K | +0.07 pp |
| GINN | 0.07% | $138K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $66K | — |
Showing 10 of 21 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KURA Jan avg: 5.10% median: 1.09% win: 50% σ: 27.03% n: 4 2022-04-12 → 2026-07-31 | KURA Feb avg: -1.02% median: 1.07% win: 50% σ: 9.48% n: 4 2022-04-12 → 2026-07-31 | KURA Mar avg: -4.37% median: -2.84% win: 50% σ: 7.88% n: 4 2022-04-12 → 2026-07-31 | KURA Apr avg: -5.50% median: -7.12% win: 20% σ: 10.64% n: 5 2022-04-12 → 2026-07-31 | KURA May avg: 7.15% median: 5.05% win: 60% σ: 20.04% n: 5 2022-04-12 → 2026-07-31 | KURA Jun avg: 5.51% median: 1.41% win: 60% σ: 21.64% n: 5 2022-04-12 → 2026-07-31 | KURA Jul avg: -5.95% median: -1.32% win: 40% σ: 10.49% n: 5 2022-04-12 → 2026-07-31 | KURA Aug avg: 4.36% median: -1.84% win: 50% σ: 18.02% n: 4 2022-04-12 → 2026-07-31 (current) | KURA Sep avg: -1.20% median: -4.33% win: 25% σ: 9.30% n: 4 2022-04-12 → 2026-07-31 | KURA Oct avg: 1.97% median: 3.14% win: 50% σ: 15.16% n: 4 2022-04-12 → 2026-07-31 | KURA Nov avg: 0.07% median: 8.02% win: 75% σ: 23.78% n: 4 2022-04-12 → 2026-07-31 | KURA Dec avg: -2.03% median: -17.76% win: 25% σ: 33.98% n: 4 2022-04-12 → 2026-07-31 |